,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
178,.,.,OMIM|low_frequency,.,.,CS000086,605462;109400;610828,"Basal cell carcinoma, somatic;Basal cell nevus syndrome;Holoprosencephaly 7","1.$$$mimNumber,109400###prefix,####preferredTitle,BASAL CELL NEVUS SYNDROME; BCNS###inheritance,Autosomal dominant ###headAndNeckFace,Broad facies ;###headAndNeckFace,Frontal and biparietal bossing ;###headAndNeckFace,Mild mandibular prognathism ;###headAndNeckFace,Odontogenic keratocysts of jaws ###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Lateral displacement of the inner canthi ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Subconjunctival epithelial cysts ;###headAndNeckEyes,Iris coloboma ;###headAndNeckEyes,Glaucoma ;###headAndNeckEyes,Medullated (myelinated) retinal nerve fibers ###headAndNeckNose,Broad nasal root ###headAndNeckMouth,Cleft lip ;###headAndNeckMouth,Cleft palate ###cardiovascularHeart,Cardiac fibroma ###respiratoryLung,Congenital lung cyst ###chestRibsSternumClaviclesAndScapulae,Bifid ribs ;###chestRibsSternumClaviclesAndScapulae,Synostotic ribs ;###chestRibsSternumClaviclesAndScapulae,Hypoplastic ribs ###abdomenGastrointestinal,Lymphomesenteric cysts, often calcified ;###abdomenGastrointestinal,Hamartomatous stomach polyps ###genitourinaryInternalGenitaliaFemale,Ovarian fibromata ;###genitourinaryInternalGenitaliaFemale,Ovarian carcinoma ###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,Abnormal cervical vertebrae ###skeletalLimbs,Brachydactyly ;###skeletalLimbs,Short 4th metacarpal ;###skeletalLimbs,Short thumb terminal phalanx ###skinNailsHairSkin,Basal cell nevi ;###skinNailsHairSkin,Basal cell carcinoma ;###skinNailsHairSkin,Pits of palms and soles ###neurologicCentralNervousSystem,Mental retardation (less common) ;###neurologicCentralNervousSystem,Calicification of the falx cerebri ;###neurologicCentralNervousSystem,Medulloblastoma ###miscellaneous,Paternal age effect ;###miscellaneous,Abnormal sensitivity to therapeutic radiation ###molecularBasis,Caused by mutation in the human homolog of the Drosophila 'patched' gene 1 (PTCH1, );###molecularBasis,Caused by mutation in the human homolog of the Drosophila 'patched' gene 2 (PTCH2, );###molecularBasis,Caused by mutation in the human homolog of the Drosophila suppressor of fused gene (SUFU, ) 2.$$$mimNumber,610828###prefix,####preferredTitle,HOLOPROSENCEPHALY 7; HPE7###inheritance,Autosomal dominant ###headAndNeckHead,Macrocephaly ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Hypoplastic premaxilla###headAndNeckEyes,Upslanting palpebral fissures ;###headAndNeckEyes,Hypotelorism ###headAndNeckNose,Hypoplastic nose (in 1 patient) ;###headAndNeckNose,Flattened alae;###headAndNeckNose,Flattened nasal tip ###headAndNeckMouth,Cleft lip ;###headAndNeckMouth,Cleft palate ###headAndNeckTeeth,Single central maxillary incisor ###abdomenExternalFeatures,Omphalocele (in 1 patient) ###neurologicCentralNervousSystem,Holoprosencephaly, semilobar or alobar;###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Agenesis of corpus callosum ;###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Seizures ###endocrineFeatures,Panhypopituitarism ###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the patched 1 gene (PTCH1, )",https://www.omim.org/entry/605462;https://www.omim.org/entry/109400;https://www.omim.org/entry/610828,.,Autosomal dominant,Het,9,98229391,G,A,.,.,PASS,0/1:62:114,54.39,"A,AAAAA..A.,AAA.A.A....AA.A.A.A...AAAA..A..AA.A.AA.a.AA..AA...A.A.A.A,,A.AAAA.A,AA.A.,A.aA..aAAA.,.,A.A^]a",splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant;splice_region_variant,PTCH1,5727,.,NM_001083605.1(PTCH1):c.2107+7C>T;NM_000264.3(PTCH1):c.2560+7C>T;NM_001083604.1(PTCH1):c.2107+7C>T;NM_001083607.1(PTCH1):c.2107+7C>T;NM_001083603.1(PTCH1):c.2557+7C>T;NM_001083602.1(PTCH1):c.2362+7C>T;NM_001083606.1(PTCH1):c.2107+7C>T,NM_000264.3,intron15(23);intron15(23);intron15(23);intron15(23);intron15(23);intron15(23);intron15(23),.;.;.;.;.;.;.,0.0079,0.0016,0,0,0.0005,0.0067,0.0004,0.0068,1,62,0.0072,1,64,0.00053,0.017667844523,15/849,http://exac.broadinstitute.org/variant/9-98229391-G-A,2.86,42.3,1,1.0,http://exac.broadinstitute.org/gene/ENSG00000185920,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs75576651,.,.,.,.,.,.,.,.,.,.,.,.,.,135881,https://www.ncbi.nlm.nih.gov/clinvar/variation/135881,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,brain development (GO:0007420)|branching involved in ureteric bud morphogenesis (GO:0001658)|cell differentiation involved in kidney development (GO:0061005)|cell proliferation involved in metanephros development (GO:0072203)|cellular response to cholesterol (GO:0071397)|dorsal/ventral pattern formation (GO:0009953)|embryonic limb morphogenesis (GO:0030326)|embryonic organ development (GO:0048568)|epidermis development (GO:0008544)|glucose homeostasis (GO:0042593)|heart morphogenesis (GO:0003007)|hindlimb morphogenesis (GO:0035137)|in utero embryonic development (GO:0001701)|keratinocyte proliferation (GO:0043616)|limb morphogenesis (GO:0035108)|mammary gland duct morphogenesis (GO:0060603)|mammary gland epithelial cell differentiation (GO:0060644)|negative regulation of cell division (GO:0051782)|negative regulation of epithelial cell proliferation (GO:0050680)|negative regulation of multicellular organism growth (GO:0040015)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|negative regulation of smoothened signaling pathway (GO:0045879)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|neural plate axis specification (GO:0021997)|neural tube closure (GO:0001843)|neural tube patterning (GO:0021532)|organ morphogenesis (GO:0009887)|pharyngeal system development (GO:0060037)|positive regulation of cholesterol efflux (GO:0010875)|protein processing (GO:0016485)|protein targeting to plasma membrane (GO:0072661)|regulation of mitotic cell cycle (GO:0007346)|regulation of protein localization (GO:0032880)|regulation of smoothened signaling pathway (GO:0008589)|renal system development (GO:0072001)|response to chlorate (GO:0010157)|response to drug (GO:0042493)|response to estradiol (GO:0032355)|response to mechanical stimulus (GO:0009612)|response to retinoic acid (GO:0032526)|smoothened signaling pathway (GO:0007224)|smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)|somite development (GO:0061053)|spinal cord motor neuron differentiation (GO:0021522),axonal growth cone (GO:0044295)|caveola (GO:0005901)|dendritic growth cone (GO:0044294)|integral component of membrane (GO:0016021)|intracellular membrane-bounded organelle (GO:0043231)|midbody (GO:0030496)|perinuclear region of cytoplasm (GO:0048471)|plasma membrane (GO:0005886)|postsynaptic density (GO:0014069)|primary cilium (GO:0072372),cholesterol binding (GO:0015485)|cyclin binding (GO:0030332)|hedgehog family protein binding (GO:0097108)|hedgehog receptor activity (GO:0008158)|heparin binding (GO:0008201)|smoothened binding (GO:0005119),.,.,.,.,38,0,CS000086
392,.,.,HGMD|OMIM|lowVAF,Name=LowComplexity,.,CS000086,611105,Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,"1.$$$mimNumber,611105###prefix,####preferredTitle,LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL###inheritance,Autosomal recessive ###headAndNeckEyes,Nystagmus ###skeletal,Joint contractures (with age) ###muscleSoftTissue,Muscle atrophy ;###muscleSoftTissue,Muscle weakness ###neurologicCentralNervousSystem,Delayed motor development ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Tremor ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Cognitive deficits (less common) ;###neurologicCentralNervousSystem,Dysarthria (less common) ;###neurologicCentralNervousSystem,Leukoencephalopathy in the periventricular and deep white matter and brainstem, cerebellum, and spinal cord tracts ;###neurologicCentralNervousSystem,Lesions are symmetrical ;###neurologicCentralNervousSystem,Magnetic resonance spectroscopy shows increased lactate in white matter ###neurologicPeripheralNervousSystem,Peripheral axonal neuropathy ;###neurologicPeripheralNervousSystem,Hyporeflexia ;###neurologicPeripheralNervousSystem,Decreased proprioception and vibration sense ###miscellaneous,Variable severity ;###miscellaneous,Onset between age 2 and 15 years ;###miscellaneous,Slowly progressive ;###miscellaneous,One patient with episodic ataxia and later onset has been reported (as of June 2010) ###molecularBasis,Caused by mutation in the aspartyl-tRNA synthetase 2 gene (DARS2, )",https://www.omim.org/entry/611105,.,Autosomal recessive,Het,1,173797452,C,-,.,.,PASS,0/1:12:85,14.12,".$.$,,...$..,..,,.-1C.-1C..,........,+1c.,-1c,.,-1c.-1C.....$...,.,.,.,,..........,..,-1c,.,....,,-1c,,.-1C.,,-1c..,-1c,+1c,,,,-1c,,,,.,,,-1c,^].^].",intron_variant,DARS2,55157,.,NM_018122.4(DARS2):c.228-10delC,NM_018122.4,intron2(16),.,0.003,0.021,0,0,0.0073,0.0092,0.0017,0.0007,0,171,0.024,1,2774,0.027,0.00117785630153,1/849,http://exac.broadinstitute.org/variant/1-173797451-TC-T,0.56,29.4,18,0.0,http://exac.broadinstitute.org/gene/ENSG00000117593,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"NM_018122.4(DARS2):c.228-16C>A,NM_018122.4(DARS2):c.228-16C>G,DM,Leukoencephalopathy, brain & spine involvement, lactate elevation,Leukoencephalopathy with brainstem & spinal cord involvement,17384640,23065766;NM_018122.4(DARS2):c.228-22T>A,NM_018122.4(DARS2):c.228-22T>C,DM?,DM,Leukoencephalopathy, brain & spine involvement, lactate elevation,21815884,22677571",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,gene expression (GO:0010467)|mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)|tRNA aminoacylation (GO:0043039)|tRNA aminoacylation for protein translation (GO:0006418),mitochondrial matrix (GO:0005759)|mitochondrion (GO:0005739)|nucleus (GO:0005634),aspartate-tRNA ligase activity (GO:0004815)|aspartate-tRNA(Asn) ligase activity (GO:0050560)|ATP binding (GO:0005524)|protein homodimerization activity (GO:0042803)|tRNA binding (GO:0000049),.,.,.,.,99,3,CS000086
495,.,.,OMIM|low_frequency,"Name=GCcontent,SegmentalDuplications",.,CS000086,600274;168600;172700;601104;260540,"Dementia, frontotemporal, with or without parkinsonism;Parkinson disease, susceptibility to;Pick disease;Supranuclear palsy, progressive;Supranuclear palsy, progressive atypical","1.$$$mimNumber,600274###prefix,####preferredTitle,FRONTOTEMPORAL DEMENTIA; FTD###inheritance,Autosomal dominant ###neurologicCentralNervousSystem,Frontal lobe dementia ;###neurologicCentralNervousSystem,Language impairment ;###neurologicCentralNervousSystem,Word-finding difficulties ;###neurologicCentralNervousSystem,Decrease in abstract thinking ;###neurologicCentralNervousSystem,Motor symptoms may be present ;###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Amyotrophic lateral sclerosis ;###neurologicCentralNervousSystem,Cortical and subcortical neuronal loss in the frontal and temporal regions ;###neurologicCentralNervousSystem,Tau-positive inclusions may be found ;###neurologicCentralNervousSystem,Ubiquitin-positive inclusions ;###neurologicCentralNervousSystem,Primitive reflexes (palmomental, snout, glabellar) ###neurologicBehavioralPsychiatricManifestations,Personality changes ;###neurologicBehavioralPsychiatricManifestations,Lack of motivation ;###neurologicBehavioralPsychiatricManifestations,Inappropriate laughter ;###neurologicBehavioralPsychiatricManifestations,Apathy ;###neurologicBehavioralPsychiatricManifestations,Irritability ;###neurologicBehavioralPsychiatricManifestations,Disinhibition ;###neurologicBehavioralPsychiatricManifestations,Kluver-Bucy syndrome ;###neurologicBehavioralPsychiatricManifestations,Inappropriate sexual behavior ;###neurologicBehavioralPsychiatricManifestations,Hyperphagia ;###neurologicBehavioralPsychiatricManifestations,Hyperoralia ###miscellaneous,Mean age at onset 45 years ;###miscellaneous,Highly variable phenotype that includes several subtypes (see, e.g., );###miscellaneous,Genetic heterogeneity (see, e.g., ;###miscellaneous,Most cases do not have mutations in the MAPT gene, but map to chromosome 17q ###molecularBasis,Caused by mutation in the microtubule-associated tau protein gene (MAPT, );###molecularBasis,Caused by mutation in the presenilin-1 gene (PSEN1, ) 2.$$$mimNumber,168600###prefix,####preferredTitle,PARKINSON DISEASE, LATE-ONSET; PD###inheritance,Isolated cases ;###inheritance,Multifactorial ###headAndNeckFace,Masked facies ###headAndNeckNose,Decreased sense of smell ###abdomenGastrointestinal,Dysphagia ;###abdomenGastrointestinal,Constipation ###genitourinaryBladder,Urinary urgency ###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Bradykinesia ;###neurologicCentralNervousSystem,Rigidity ;###neurologicCentralNervousSystem,Postural instability ;###neurologicCentralNervousSystem,Resting tremor ;###neurologicCentralNervousSystem,Micrographia ;###neurologicCentralNervousSystem,Gait disturbances ;###neurologicCentralNervousSystem,Shuffling gait ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Monotonous speech ;###neurologicCentralNervousSystem,Dysautonomia may occur ;###neurologicCentralNervousSystem,Visual hallucinations may occur ;###neurologicCentralNervousSystem,Dementia may occur ;###neurologicCentralNervousSystem,Sleep disturbances ;###neurologicCentralNervousSystem,Neuronal loss and gliosis in the substantia nigra pars compacta ;###neurologicCentralNervousSystem,Loss of dopaminergic neurons ;###neurologicCentralNervousSystem,Intracellular Lewy bodies ;###neurologicCentralNervousSystem,Aggregation of SNCA-immunopositive inclusions ###neurologicBehavioralPsychiatricManifestations,Depression ###miscellaneous,Onset mid to late adulthood ;###miscellaneous,Insidious onset ;###miscellaneous,Progressive disorder ;###miscellaneous,Levodopa-responsive 3.$$$mimNumber,172700###prefix,####preferredTitle,PICK DISEASE OF BRAIN###inheritance,Isolated cases ;###inheritance,Autosomal dominant ###neurologicCentralNervousSystem,Frontotemporal dementia ;###neurologicCentralNervousSystem,Language impairment ;###neurologicCentralNervousSystem,Frontotemporal lobar atrophy with 'knife-edge' distinction ;###neurologicCentralNervousSystem,Atrophy may be more severe in the left hemisphere ;###neurologicCentralNervousSystem,Primitive reflexes (palmomental, snout, glabellar) ;###neurologicCentralNervousSystem,Argyrophilic hyperphosphorylated tau-positive inclusions (Pick bodies) ;###neurologicCentralNervousSystem,Swollen achromatic cells (Pick cells) ;###neurologicCentralNervousSystem,Pick bodies found in neocortical layers, granule cells of the dentate gyrus, and throughout the hippocampus ;###neurologicCentralNervousSystem,Neuronal loss ;###neurologicCentralNervousSystem,Astrogliosis ###neurologicBehavioralPsychiatricManifestations,Personality changes ;###neurologicBehavioralPsychiatricManifestations,Lack of motivation ;###neurologicBehavioralPsychiatricManifestations,Emotional blunting ;###neurologicBehavioralPsychiatricManifestations,Inappropriate laughter ;###neurologicBehavioralPsychiatricManifestations,Apathy ;###neurologicBehavioralPsychiatricManifestations,Irritability ;###neurologicBehavioralPsychiatricManifestations,Disinhibition ;###neurologicBehavioralPsychiatricManifestations,Hyperphagia ;###neurologicBehavioralPsychiatricManifestations,Hyperoralia ;###neurologicBehavioralPsychiatricManifestations,Perseveration ;###neurologicBehavioralPsychiatricManifestations,Stereotyped behavior ;###neurologicBehavioralPsychiatricManifestations,Echolalia ###miscellaneous,Phenotypic overlap with frontotemporal dementia ()###molecularBasis,Caused by mutation in the microtubule-associated tau protein gene (MAPT, );###molecularBasis,Caused by mutation in the presenilin-1 gene (PSEN1, ) 4.$$$mimNumber,601104###prefix,####preferredTitle,SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1###inheritance,Autosomal dominant ###headAndNeckEyes,Blurred vision ;###headAndNeckEyes,Diplopia ;###headAndNeckEyes,Photophobia ;###headAndNeckEyes,Eyelid apraxia ;###headAndNeckEyes,Supranuclear gaze palsy ###abdomenGastrointestinal,Dysphagia ###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Bradykinesia ;###neurologicCentralNervousSystem,Akinesia ;###neurologicCentralNervousSystem,Rigidity ;###neurologicCentralNervousSystem,Axial dystonia ;###neurologicCentralNervousSystem,Poor mobility ;###neurologicCentralNervousSystem,Gait imbalance ;###neurologicCentralNervousSystem,Falls ;###neurologicCentralNervousSystem,Supranuclear gaze palsy ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Retrocollis ;###neurologicCentralNervousSystem,Tremor (30%) ;###neurologicCentralNervousSystem,Limb dystonia (18%) ;###neurologicCentralNervousSystem,Mutism ;###neurologicCentralNervousSystem,Frontolimbic dementia ;###neurologicCentralNervousSystem,Neuropathology shows neuronal loss in basal ganglia, brainstem, and cerebellum ;###neurologicCentralNervousSystem,Tau-immunoreactive inclusions in neurons and astrocytes ;###neurologicCentralNervousSystem,Tau inclusions are 'flame-shaped' or 'tuft-like' ;###neurologicCentralNervousSystem,Granulovacuolar degeneration ;###neurologicCentralNervousSystem,Gliosis ;###neurologicCentralNervousSystem,Neurofibrillary tangles ###neurologicBehavioralPsychiatricManifestations,Forgetfulness ;###neurologicBehavioralPsychiatricManifestations,Irritability ;###neurologicBehavioralPsychiatricManifestations,Apathy ;###neurologicBehavioralPsychiatricManifestations,Frontal release signs (45%) ###miscellaneous,Autosomal dominant with incomplete penetrance ;###miscellaneous,Average age at onset 66 years although earlier onset may occur ;###miscellaneous,Median survival 5.7 years ;###miscellaneous,May show good response to levodopa ;###miscellaneous,Genetic heterogeneity (see PSNP2 ;###miscellaneous,Phenotypic overlap with frontotemporal dementia ();###miscellaneous,Associated with the tau () H1 haplotype###molecularBasis,Caused by mutation in the microtubule-associated protein tau gene (MAPT, ) ",https://www.omim.org/entry/600274;https://www.omim.org/entry/168600;https://www.omim.org/entry/172700;https://www.omim.org/entry/601104;https://www.omim.org/entry/260540,.,"Autosomal dominant;Isolated cases, Multifactorial;Autosomal dominant, Isolated cases;Autosomal recessive",Het,17,44060564,G,A,.,.,PASS,0/1:28:63,44.44,",$,Aa,,A,,aa,aa,aaa,,aa,.,,,a,.A.,,,,aa,a.,a,a,,aA,,,aAa,.a.aaA,.",intron_variant;intron_variant;intron_variant;intron_variant;missense_variant;missense_variant;intron_variant;intron_variant,MAPT,4137,.,NM_001123067.3(MAPT):c.287-3842G>A;NM_005910.5(MAPT):c.374-3842G>A;NM_001203252.1(MAPT):c.374-3842G>A;NM_016834.4(MAPT):c.200-3842G>A;NM_016835.4(MAPT):c.394G>A(p.Val132Ile);NM_001123066.3(MAPT):c.394G>A(p.Val132Ile);NM_001203251.1(MAPT):c.287-3842G>A;NM_016841.4(MAPT):c.200-3842G>A,NM_005910.5,intron4(10);intron5(11);intron5(10);intron3(9);exon6(14);exon6(15);intron4(9);intron3(8),.;.;.;.;NP=>NP;NP=>NP;.;.,.,.,0,0,1.714e-05,0.0002,3.239e-05,0.0006,0,1,0.00016,0,2,0.000027,0.00117785630153,1/849,http://exac.broadinstitute.org/variant/17-44060564-G-A,1.51,18.8,10,0.0,http://exac.broadinstitute.org/gene/ENSG00000186868; ENSG00000277956; ENSG00000276155,0.28003,.,0.18,T,0.587,P,0.266,B,0.104,N,1.000,N,-0.556,11.20,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,adult walking behavior (GO:0007628)|apoptotic process (GO:0006915)|axon cargo transport (GO:0008088)|axon extension (GO:0048675)|cellular component disassembly involved in execution phase of apoptosis (GO:0006921)|generation of neurons (GO:0048699)|microtubule cytoskeleton organization (GO:0000226)|mitochondrion transport along microtubule (GO:0047497)|negative regulation of intracellular transport (GO:0032387)|neuron migration (GO:0001764)|positive regulation of axon extension (GO:0045773)|positive regulation of microtubule polymerization (GO:0031116)|regulation of autophagy (GO:0010506)|regulation of microtubule polymerization (GO:0031113)|regulation of microtubule-based movement (GO:0060632),axon (GO:0030424)|axoneme (GO:0005930)|cytoplasmic ribonucleoprotein granule (GO:0036464)|cytosol (GO:0005829)|growth cone (GO:0030426)|microtubule (GO:0005874)|microtubule associated complex (GO:0005875)|nuclear periphery (GO:0034399)|plasma membrane (GO:0005886)|tubulin complex (GO:0045298),apolipoprotein binding (GO:0034185)|enzyme binding (GO:0019899)|lipoprotein particle binding (GO:0071813)|microtubule binding (GO:0008017)|SH3 domain binding (GO:0017124)|structural constituent of cytoskeleton (GO:0005200),.,.,.,.,88,2,CS000086
524,.,.,HGMD|OMIM,Name=LowComplexity,.,CS000086,607426;146500,"Coenzyme Q10 deficiency, primary, 1;Multiple system atrophy, susceptibility to","1.$$$mimNumber,607426###prefix,####preferredTitle,COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1###inheritance,Autosomal recessive ###headAndNeckEars,Deafness, sensorineural ###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Vision loss ;###headAndNeckEyes,Retinitis pigmentosa ###cardiovascularHeart,Hypertrophic cardiomyopathy ###abdomenLiver,Liver failure ###genitourinaryKidneys,Nephrotic syndrome ;###genitourinaryKidneys,Glomerulosclerosis ;###genitourinaryKidneys,Podocyte effacement ;###genitourinaryKidneys,Abnormal mitochondria in podocytes ###muscleSoftTissue,Muscle weakness, progressive ;###muscleSoftTissue,Exertional fatigue ;###muscleSoftTissue,Lipid accumulation ;###muscleSoftTissue,Decreased coenzyme Q10 content ;###muscleSoftTissue,Ragged red fibers ###neurologicCentralNervousSystem,Encephalopathy ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Cerebellar ataxia ;###neurologicCentralNervousSystem,Cerebellar atrophy ###metabolicFeatures,Lactic acidemia ###hematology,Anemia ;###hematology,Pancytopenia ###laboratoryAbnormalities,Decreased levels of coenzyme Q10 in skeletal muscle (5-35%) ;###laboratoryAbnormalities,Decreased activity of coenzyme Q10-dependent respiratory chain complexes ;###laboratoryAbnormalities,Increased serum creatine kinase ###miscellaneous,Highly variable phenotype ;###miscellaneous,Onset usually in infancy or early childhood ;###miscellaneous,Some patients may show a favorable response to oral Coenzyme Q10 supplementation ###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae Coq2 gene (COQ2, ) 2.$$$mimNumber,146500###prefix,####preferredTitle,MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###headAndNeckEyes,Gaze-evoked nystagmus ;###headAndNeckEyes,Extraocular movement difficulties ###cardiovascularVascular,Orthostatic hypotension ###genitourinaryExternalGenitaliaMale,Erectile dysfunction ###genitourinaryBladder,Urinary incontinence ;###genitourinaryBladder,Incomplete bladder emptying ;###genitourinaryBladder,Urinary urgency ###skinNailsHairSkin,Decreased sweating ###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Bradykinesia ;###neurologicCentralNervousSystem,Rigidity ;###neurologicCentralNervousSystem,Tremor ;###neurologicCentralNervousSystem,Postural instability ;###neurologicCentralNervousSystem,Cerebellar ataxia ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Autonomic dysfunction ;###neurologicCentralNervousSystem,Mild cognitive impairment (in some patients) ;###neurologicCentralNervousSystem,Neuropathology shows alpha-synuclein-containing cytoplasmic inclusions in glial cells ;###neurologicCentralNervousSystem,Neurodegeneration in the cerebellum ;###neurologicCentralNervousSystem,Neurodegeneration in the basal ganglia ;###neurologicCentralNervousSystem,Neurodegeneration in the substantia nigra ;###neurologicCentralNervousSystem,Nigrostriatal degeneration ;###neurologicCentralNervousSystem,Olivopontocerebellar degeneration ###miscellaneous,Onset in middle age ;###miscellaneous,Progressive disorder ;###miscellaneous,Variable phenotype ;###miscellaneous,Poor response to L-dopa treatment ;###miscellaneous,Heterozygous, homozygous, and compound heterozygous COQ2 mutations have been identified ###molecularBasis,Susceptibility conferred by mutation in the homolog of the S. cerevisiae COQ2 gene (COQ2, ).",https://www.omim.org/entry/607426;https://www.omim.org/entry/146500,.,"Autosomal recessive;Autosomal recessive, Autosomal dominant",Het,4,84185440,A,G,.,.,PASS,0/1:43:77,55.84,".$Ggg.,G,G,g.,GG,,.GgG.,GGg.,g...ggG,Gggg..,GggGGGG,.gGg.,G..,,GgGgg,g",missense_variant,COQ2,27235,.,NM_015697.7(COQ2):c.1178T>C(p.Val393Ala),NM_015697.7,exon7(7),NP=>NP,0.018,0.0064,0,0,0.0041,0.0158,0.0014,0.0154,1,143,0.017,8,439,0.0036,0.0353356890459,30/849,http://exac.broadinstitute.org/variant/4-84185440-A-G,-0.04,10.5,7,0.0,http://exac.broadinstitute.org/gene/ENSG00000173085,0.30955,.,0,D,0.285,B,0.138,B,0.374,N,1.000,N,6.17,11.80,rs148156462,.,.,.,.,NM_015697.7(COQ2):c.1178T>C(p.V393A),DFP,"Multiple system atrophy, increased risk, association with",23758206,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell death (GO:0008219)|glycerol metabolic process (GO:0006071)|isoprenoid biosynthetic process (GO:0008299)|small molecule metabolic process (GO:0044281)|ubiquinone biosynthetic process (GO:0006744),integral component of membrane (GO:0016021)|mitochondrial inner membrane (GO:0005743),4-hydroxybenzoate decaprenyltransferase activity (GO:0002083)|4-hydroxybenzoate nonaprenyltransferase activity (GO:0047293),.,.,.,.,45,1,CS000086
